Foresight Diagnostics
Foresight Diagnostics is a molecular diagnostics company specializing in non-invasive cancer detection technologies, translating advanced scientific methods into clinically meaningful solutions. The organization fosters a collaborative work environment focused on quality, innovation, and professional growth, supporting impactful programs in a cutting-edge field.
Headquarters
Boulder, Colorado, United States
Company Size
51-200 employees
Founded
2020
Foresight Diagnostics is a biotechnology company focused on advancing cancer diagnostics through innovative technology. Specializing in precision genomics and bioinformatics, Foresight develops tests like Foresight CLARITY™, which utilizes advanced methods to detect minimal residual disease and improve patient outcomes. Collaborating with biopharma and academic researchers, Foresight is committed to enhancing clinical decision-making and drug development in oncology.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Foresight Diagnostics.
Natera Acquires Foresight Diagnostics
Dec 5, 2025
Associate Research Scientist II
Abbott Laboratories
Associate Research Scientist II
Abbott Laboratories
Associate Research Scientist II
Abbott Laboratories
Industrial Postdoc - Molecular Biology (mNGS Project)
Clear Labs
Senior Scientist Applications - Pathogen
Ellison Institute of Technology
Clinical Laboratory Scientist
DELFI Diagnostics, Inc.